CANY
RCUS icon

Caxton Associates (New York)’s Arcus Biosciences RCUS Stock Holding History

Caxton Associates (New York)’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,387
Closed -$461K – 638
2021
Q4 		$461K Buy
+11,387
New +$461K 0.05% 275